Regeneron Pharmaceuticals

World Rank (Jul-30-2023)
174
Market Cap (Jul-30-2023)
81.855 Billion USD
World Rank (Dec-25-2022)
166
Market Cap (Dec-25-2022)
79.143 Billion USD
World Rank (Jan-07-2022)
279
Market Cap (Jan-07-2022)
64.927 Billion USD
World Rank (Jan-01-2021)
308
Market Cap (Jan-01-2021)
51.551 Billion USD
Company Rank in Country in 2023
Company Rank in USA in July-2023 is 97
Annual Revenue in USD
12,172 Million USD
Annual Net Income in USD
4,338 Million USD
Total Assets in USD
29,214 Million USD
Total Liabilities in USD
6,550 Million USD
Annual Results for Year ending in
Dec-2022 month
Headquarters State / City
New York
Headquarters Country
USA
Company Business
Healthcare
Pharmaceutical
Biopharmaceutical
Biotechnology
HealthCare Products
Stock Category
S&P 500
Nasdaq 100
Stock Exchange
Nasdaq
Company Rank in Country in 2022
Company Rank in USA in 2022 is 142
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 150
Rank in Country (Jan-2020)
Rank in USA in 2020 is 173
Number of Employees
11,851
Employee Count as on Date
As on Dec-2022
CEO:
Leonard Schleifer
Founders
Leonard Schleifer
Eric Manvers Shooter
Yahoo
Yahoo @ Nasdaq
Wikipedia
Wikipedia
Facebook
Facebook
Company Website:
REGENERON PHARMACEUTICALS INC
About Company Business:

REGENERON PHARMACEUTICALS is Bio-Pharmaceutical company with headquarters in New York, USA.

As on 2022, REGENERON PHARMACEUTICALS has 11,851 employees.

Facts About Company

REGENERON PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 12,172 million USD.

REGENERON PHARMACEUTICALS annual net income generated for period ending Dec-2022 was 4,338 million USD.

As on 2022, they had 11,851 employees. They had 7 FDA approved medicines.

IPO Year
1991
Founded Year
1988
Annual Results Summary:

REGENERON PHARMACEUTICALS - Annual Results Summary - in Million USD

Year Ending: Total Revenue Operating Income Net Income
Dec-2022 12,172 4,994 4,338
Dec-2021 16,071 8,946 8,075
Dec-2020 8,497 3,576 3,513
Dec-2019 7,863 2,209 2,115
Dec-2018 6,710 2,534 2,444
Dec-2017 5,872 2,079 1,198
Balance Sheet Summary

Total Assets as on Dec-2022 was 29,214 Million USD.

Total Liabilities as on Dec-2022 was 6,550 Million USD.

Total Equity as on Dec-2022 was 22,664 Million USD.

Quarterly Results Summary:

REGENERON PHARMACEUTICALS - Quarterly Results Summary - in Million USD

Quarterly Ending:

 Total Revenue Operating-Income Net Income
Sep-2023 3,362 1,211 1,007
Jun-2023 3,158 1,016 968
Mar-2023 3,162 1,002 817
Dec-2022 3,414 1,176 1,197
Sep-2022 2,936 1,223 1,315
Jun-2022 2,857 1,306 852
Mar-2022 2,965 1,286 973
Dec-2021 4,951 2,639 2,229
Sep-2021 3,452 1,847 1,632
Institutional Investors

Top 30 Institutional Holder Names in REGENERON PHARMACEUTICALS as on SEP-30-2023

RANK INSTITUTION NAME DATE SHARES HELD CHANGE (SHARES) CHANGE (%) VALUE (IN 1,000S)
1 FMR LLC 09/30/2023 98,40,892 6,69,517 7.30% $7,797,726
2 BLACKROCK INC. 09/30/2023 88,75,309 -2,10,673 -2.32% $7,032,617
3 VANGUARD GROUP INC 09/30/2023 87,98,505 -58,533 -0.66% $6,971,759
4 JPMORGAN CHASE & CO 09/30/2023 73,89,154 8,45,167 12.92% $5,855,018
5 CAPITAL WORLD INVESTORS 09/30/2023 51,07,339 -4,43,043 -7.98% $4,046,953
6 STATE STREET CORP 09/30/2023 48,29,106 -1,61,764 -3.24% $3,826,487
7 CAPITAL INTERNATIONAL INVESTORS 09/30/2023 29,74,338 17,723 0.60% $2,356,806
8 DODGE & COX 09/30/2023 23,72,998 -21,357 -0.89% $1,880,316
9 GEODE CAPITAL MANAGEMENT, LLC 09/30/2023 23,19,986 38,857 1.70% $1,838,311
10 PRICE T ROWE ASSOCIATES INC /MD/ 09/30/2023 22,17,665 -34,598 -1.54% $1,757,233
11 WELLINGTON MANAGEMENT GROUP LLP 09/30/2023 15,06,885 -1,62,047 -9.71% $1,194,026
12 WESTWOOD HOLDINGS GROUP INC 12/31/2022 14,97,842 14,80,215 8397.43% $1,186,860
13 LOOMIS SAYLES & CO L P 09/30/2023 12,32,879 -44,605 -3.49% $976,909
14 PUTNAM INVESTMENTS LLC 09/30/2023 11,86,406 17,085 1.46% $940,084
15 NORTHERN TRUST CORP 09/30/2023 10,67,210 34,326 3.32% $845,636
16 MORGAN STANLEY 09/30/2023 9,70,957 25,792 2.73% $769,367
17 BANK OF NEW YORK MELLON CORP 09/30/2023 9,67,414 2,666 0.28% $766,560
18 NORGES BANK 12/31/2022 9,66,467 59,854 6.60% $765,809
19 AMERICAN CENTURY COMPANIES INC 09/30/2023 9,16,718 30,050 3.39% $726,389
20 BANK OF AMERICA CORP /DE/ 09/30/2023 8,36,859 -1,686 -0.20% $663,110
21 LEGAL & GENERAL GROUP PLC 09/30/2023 8,20,208 -26,921 -3.18% $649,916
22 INVESCO LTD. 09/30/2023 7,43,348 -1,65,714 -18.23% $589,014
23 NEUBERGER BERMAN GROUP LLC 09/30/2023 7,07,811 -852 -0.12% $560,855
24 UBS ASSET MANAGEMENT AMERICAS INC 09/30/2023 6,95,387 29,203 4.38% $551,011
25 ALLIANCEBERNSTEIN L.P. 09/30/2023 6,92,258 4,399 0.64% $548,531
26 AMUNDI 09/30/2023 6,85,286 574 0.08% $543,007
27 DIMENSIONAL FUND ADVISORS LP 09/30/2023 6,19,266 6,442 1.05% $490,694
28 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 09/30/2023 5,98,058 -1,978 -0.33% $473,889
29 EP WEALTH ADVISORS, LLC 06/30/2023 5,69,130 -39,80,870 -87.49% $450,967
30 FRANKLIN RESOURCES INC 09/30/2023 4,83,210 -5,454 -1.12% $382,886

Share it on Social Media